LanthaScreen™ TR-FRET PPAR gamma Competitive Binding Assay Kit, goat
Product Image

LanthaScreen™ TR-FRET PPAR gamma Competitive Binding Assay Kit, goat

Dieses Kit enthält Ziege-Tb-Anti-GST-Antikörper; die anderen Kit-Komponenten sind identisch mit Kit A15145:Der LanthaScreen™ TR-FRET kompetitive Bindungsassay für PPAR-gamma bietet eineWeitere Informationen
Have Questions?
KatalognummerMenge
PV4894400 x 40 μL
Katalognummer PV4894
Preis (EUR)
1.928,00
Each
Zum Warenkorb hinzufügen
Menge:
400 x 40 μL
Preis (EUR)
1.928,00
Each
Zum Warenkorb hinzufügen
Dieses Kit enthält Ziege-Tb-Anti-GST-Antikörper; die anderen Kit-Komponenten sind identisch mit Kit A15145:

Der LanthaScreen™ TR-FRET kompetitive Bindungsassay für PPAR-gamma bietet eine empfindliche und zuverlässige Methode für das Hochdurchsatz-Screening (HTS) von Liganden für den Peroxisom-Proliferator-aktivierten Rezeptor gamma (PPAR-gamma). Das Kit verwendet einen Terbium-markierten Anti-GST-Antikörper, einen fluoreszierenden niedermolekularen Pan-PPAR-Liganden (Fluormone™ Pan-PPAR Green) und eine humane PPAR-gamma-Liganden-bindende Domäne (LBD), die mit Glutathion S-Transferase (GST) markiert ist, in einem homogenen „Mix-and-Read“-Assay-Format.

Zur Assay-Durchführung:
Beim Lauf des LanthaScreen™ TR-FRET kompetitiven Bindungsassays für PPAR-gamma wird Fluormone™ Pan-PPAR Green zu Liganden-Testverbindungen hinzugefügt, gefolgt von einer Mischung aus der PPAR-gamma-LBD und dem Terbium-Anti-GST-Antikörper. Wenn Fluormon™ pan-PPAR Grün an PPAR-gamma gebunden ist, erfolgt eine Energieübertragung vom Terbium-markierten Antikörper zum Tracer, und es wird ein hohes TR-FRET-Verhältnis beobachtet. Die kompetitive Ligandenbindung an PPAR-gamma wird nachgewiesen mithilfe der Fähigkeit einer Testverbindung, die Markierungssubstanz zu verdrängen, was zu einem FRET-Verlust zwischen dem Antikörper und der Markierungssubstanz führt. Nach einer Inkubationszeit bei Raumtemperatur wird das 520 nm/495 nm-TR-FRET-Verhältnis berechnet und kann zur Bestimmung der IC50 anhand einer Dosisreaktionskurve der Verbindung verwendet werden (Abbildung 1). Diese Art des Bindungsassays ist analog zu Radioliganden-basierten Assays, mit dem Unterschied, dass nicht mit Radioaktivität umgegangen werden muss und ein homogenes, “reines Zugabe-Format” ermöglicht wird.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
Assay-EingabeBiochemische kompetitive Bindung
NachweisverfahrenFluoreszent
Zur Verwendung mit (Anwendung)Assay für kompetitive Bindung, TR-FRET
Zur Verwendung mit (Geräte)Mikrotiterplatten-Lesegerät
LigandPan-PPAR
Verpackung384-Well-Platte
ProdukttypTR-FRET PPAR gamma Assay-Kit für kompetitive Bindung
Menge400 x 40 μL
AnzeigewertEndpunkt
VersandbedingungTrockeneis
ZieleintragPPARG, PPAR-gamma, NR1C3
KonjugatTb (Terbium)
ProduktlinieLanthaScreen
Unit SizeEach
Inhalt und Lagerung
Das LanthaScreen™ TR-FRET-Assay-Kit für kompetitiven Bindungstest für PPAR-gamma enthält PPAR-gamma-LBD (GST)-Protein, Fluormone™ Pan-PPAR Grün, Terbium-markierten Anti-GST-Antikörper und mehrere Puffer. Lagerung der Komponenten wie im Assay-Protokoll angegeben (-80 °C, -20 °C oder +4 °C).

Häufig gestellte Fragen (FAQ)

How does the LanthaScreen technology compare to other TR-FRET assay formats?

We performed a comparison between the LanthaScreen assay and other commercially available TR-FRET assays from 2 different suppliers for the PKC kinase target. Our data revealed that the assays performed comparably, but that the LanthaScreen assay was simpler to optimize and contained fewer components that required optimization. The LanthaScreen assay is a two component system, whereas the other assay formats utilize a trimolecular mechanism which is more time consuming to optimize and has added costs.

For my kinase assay, can I pre-mix the Tb-Ab and EDTA so that I can stop the kinase assay and begin detection with a single reagent addition?

Yes, this is possible depending on the concentrations of reagents used and the time for which they are mixed. We recommend developing and optimizing the assay by using separate reagent additions, because this method will work under the widest range of conditions. Once the assay is optimized, the performance of the assay using pre-mixed antibody and EDTA can be evaluated. We have successfully developed robust assays in which the antibody and EDTA were pre-mixed and then stored overnight at 4 degrees C prior to use the following day. A loss of signal intensity was observed in this case, however, by using the ratiometric readout, this effect was minimal.

Are the LanthaScreen reagents stable to interference from Mg2+, Mn2+, and EDTA?

The chelate is completely stable to Mg2+. The amount of Mn2+ or EDTA that the chelate can tolerate depends largely on how long they are mixed together and the combination of additives used in the reaction. If a reaction requires either Mg2+ or Mn2+ for activation, it is best to stop the reaction by adding an equimolar amount (or slight excess) of EDTA to chelate the metal ions present. This will then essentially eliminate any interference on the terbium chelate by EDTA or Mn2+. Regardless, when LanthaScreen assays are performed using a ratiometric readout (division of the acceptor signal by the donor signal), any interference caused by Mn2+ or EDTA is largely cancelled out.

What is the optimal and/or maximum distance for a Tb-fluorescein pair?

The Förster radius, the distance at which energy transfer efficiency is half-maximal, is around 50-angstroms for the terbiumÆ fluorescein pair. However, the Förster radius does not give a complete indication of energy transfer efficiency when using long lifetime fluorophores such as terbium chelates. When using terbium chelates, energy transfer efficiency is determined by the distance of closest approach between the donor and acceptor during the excited state lifetime of the donor. In many assay systems, such as those designed using antibodies or peptides, there is a large degree of conformational freedom that allows the donor and acceptor to approach one another, effectively enhancing the FRET signal. Additionally, it is important to note that as the donor/acceptor pair approach one another and the efficiency of energy transfer increases, the fluorescent lifetime decreases to a comparable extent. From a practical standpoint, this means that when energy transfer is extremely efficient, FRET cannot be measured in time-resolved mode (because the energy transfer is complete before the measurement is made). This is another reason why TR-FRET assays based around terbium-labeled antibodies or streptavidin perform so well, because there exist a range of donor/acceptor distances, several of which are optimal for measuring FRET.

How many LanthaScreen assays can I run with a given amount of substrate?

It varies, depending on the concentration of substrate used in the assay. But in general, for the peptide substrates, 1 mg of peptide will run approximately 250,000 wells (10 µL reaction, 200 nM peptide). For Poly GT or GAT, the 1 mL of 30 µM size we sell is approximately 1 mg. With these substrates, 1 mL of 30 µM will run approximately 16,700 wells (10 µL reaction, 200 µM substrate).

20 nmol of our physiological protein substrates is sufficient for approximately 10,000 wells (10 µL reaction, 200 µM substrate).

Zitierungen und Referenzen (2)

Zitierungen und Referenzen
Abstract
Amorfrutins are potent antidiabetic dietary natural products.
Authors:Weidner C, de Groot JC, Prasad A, Freiwald A, Quedenau C, Kliem M, Witzke A, Kodelja V, Han CT, Giegold S, Baumann M, Klebl B, Siems K, Müller-Kuhrt L, Schürmann A, Schüler R, Pfeiffer AF, Schroeder FC, Büssow K, Sauer S,
Journal:Proc Natl Acad Sci U S A
PubMed ID:22509006
'Given worldwide increases in the incidence of obesity and type 2 diabetes, new strategies for preventing and treating metabolic diseases are needed. The nuclear receptor PPARγ (peroxisome proliferator-activated receptor gamma) plays a central role in lipid and glucose metabolism; however, current PPARγ-targeting drugs are characterized by undesirable side effects. Natural ... More
Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.
Authors:Schopfer FJ, Cole MP, Groeger AL, Chen CS, Khoo NK, Woodcock SR, Golin-Bisello F, Motanya UN, Li Y, Zhang J, Garcia-Barrio MT, Rudolph TK, Rudolph V, Bonacci G, Baker PR, Xu HE, Batthyany CI, Chen YE, Hallis TM, Freeman BA,
Journal:J Biol Chem
PubMed ID:20097754
The peroxisome proliferator-activated receptor-gamma (PPARgamma) binds diverse ligands to transcriptionally regulate metabolism and inflammation. Activators of PPARgamma include lipids and anti-hyperglycemic drugs such as thiazolidinediones (TZDs). Recently, TZDs have raised concern after being linked with increased risk of peripheral edema, weight gain, and adverse cardiovascular events. Most reported endogenous PPARgamma ... More